Pacific Health Summit
"The key challenge for us at this Summit—as laid out implicitly by the electorates, patients, and stakeholders we represent—is to grapple in practical terms with how we best integrate these opportunities into our healthcare systems. We cannot stand on the sidelines…. Healthcare needs to move from being our greatest modern cost to becoming our greatest modern asset."
–William Castell, Chairman, The Wellcome Trust; and Former CEO, GE Healthcare
NBR's Center for Health and Aging (CHA) served as the Secretariat for the Pacific Health Summit. This annual, invitation-only event welcomed 250 top leaders from science, industry, and policy each June to discuss how to realize the dream of a healthier future. Every year the Pacific Health Summit focused on a single theme designed to tackle a critical topic in global health including affordability and technologies for health (2012), vaccines (2011), maternal and newborn health (2010), multi-drug resistant tuberculosis (2009), malnutrition (2008), pandemic influenza (2007), and early health (2005 and 2006).
The Pacific Health Summit is a place where leaders established ground-breaking projects and initiatives. For example, at the 2007 Summit the Director-General of the WHO also announced the establishment of a pre-pandemic flu vaccine stockpile. Furthering the important work of the 2007 Summit, in 2009 sanofi aventis pledged 100 million doses of H5N1 flu vaccine to the WHO for developing countries. Numerous other collaborations, including the Critical Path to TB Drug Regimens (2009), an agreement to distribute innovative medical devices between Laerdal & Powerfree Education and Technology (2010), and a pneumoccoccal vaccine collaboration between Merck & Co. and Serum Institute (2011) either were futhered by or began at meetings held at the Summit.
To learn more about the Summit's impact, visit The Pacific Health Summit's website.